Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
25.7M
-
Shares change
-
+1.29M
-
Total reported value, excl. options
-
$277M
-
Value change
-
+$14M
-
Number of buys
-
37
-
Number of sells
-
-34
-
Price
-
$10.76
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2016
99 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q2 2016.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.7M shares
of 37.4M outstanding shares and own 68.7% of the company stock.
Largest 10 shareholders include NWQ INVESTMENT MANAGEMENT COMPANY, LLC (2.85M shares), FRANKLIN RESOURCES INC (2.85M shares), WYNNEFIELD CAPITAL INC (2.68M shares), DIMENSIONAL FUND ADVISORS LP (2.25M shares), ARIEL INVESTMENTS, LLC (1.59M shares), VANGUARD GROUP INC (1.17M shares), ROYAL BANK OF CANADA (1.06M shares), ROYCE & ASSOCIATES LP (1.06M shares), HEARTLAND ADVISORS INC (990K shares), and BlackRock Institutional Trust Company, N.A. (814K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.